Literature DB >> 16699754

Multiple cryptic splice sites can be activated by IDS point mutations generating misspliced transcripts.

Susanna Lualdi1, Maria G Pittis, Stefano Regis, Rossella Parini, Anna E Allegri, Francesca Furlan, Bruno Bembi, Mirella Filocamo.   

Abstract

Mutations in the gene encoding the enzyme iduronate-2-sulfatase (IDS) were reported as the cause of the X-linked recessive lysosomal disease, mucopolysaccharidosis II (MPS II). Amongst the different mutations, it emerges that nearly 10% are nucleotide substitutions causing splicing mutations. We now report the molecular characterisation of three MPS II patients with multiple aberrant transcripts due to three different point mutations. The c.418+1G>C that occurred in the invariant splice-site motif, produced only aberrantly spliced transcripts. Whilst the mutations affecting variant motifs (c.419G>T) or coding regions (c.245C>T) led to aberrantly spliced transcripts in addition to correctly spliced transcripts with the respective predicted missense mutation, p.G140V or p.A82V. A combination of experimental tests and computational approaches were used to understand the molecular basis underlying the altered transcription patterns. In addition, by using real-time reverse transcriptase polymerase chain reaction, the reduction of mRNA amount in two patients observed was likely due to nonsense-mediated mRNA decay pathway. Overall, our results further emphasised the importance of cloning and sequencing independent transcripts to reveal less abundant, aberrant products, which often could not be detected by direct sequencing. Moreover, the different splicing patterns observed in the three patients as a consequence of point mutations show how sensitive the balance is between constitutive and cryptic splice sites in the IDS gene. The generation of such diverse transcripts, together with their level of expression, could contribute to the profound phenotypic variability reported in MPS II.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16699754     DOI: 10.1007/s00109-006-0057-1

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  23 in total

Review 1.  Splicing regulation as a potential genetic modifier.

Authors:  Malka Nissim-Rafinia; Batsheva Kerem
Journal:  Trends Genet       Date:  2002-03       Impact factor: 11.639

2.  Predictive identification of exonic splicing enhancers in human genes.

Authors:  William G Fairbrother; Ru-Fang Yeh; Phillip A Sharp; Christopher B Burge
Journal:  Science       Date:  2002-07-11       Impact factor: 47.728

Review 3.  Nonsense-mediated mRNA decay in mammals.

Authors:  Lynne E Maquat
Journal:  J Cell Sci       Date:  2005-05-01       Impact factor: 5.285

Review 4.  From birth to death: the complex lives of eukaryotic mRNAs.

Authors:  Melissa J Moore
Journal:  Science       Date:  2005-09-02       Impact factor: 47.728

5.  130 kb of DNA sequence reveals two new genes and a regional duplication distal to the human iduronate-2-sulfate sulfatase locus.

Authors:  K M Timms; F Lu; Y Shen; C A Pierson; D M Muzny; Y Gu; D L Nelson; R A Gibbs
Journal:  Genome Res       Date:  1995-08       Impact factor: 9.043

6.  Hunter syndrome: isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA.

Authors:  P J Wilson; C P Morris; D S Anson; T Occhiodoro; J Bielicki; P R Clements; J J Hopwood
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

7.  Evidence for an iduronate-sulfatase pseudogene near the functional Hunter syndrome gene in Xq27.3-q28.

Authors:  M Rathmann; S Bunge; C Steglich; E Schwinger; A Gal
Journal:  Hum Genet       Date:  1995-01       Impact factor: 4.132

8.  Control of 3' splice site choice in vivo by ASF/SF2 and hnRNP A1.

Authors:  Y Bai; D Lee; T Yu; L A Chasin
Journal:  Nucleic Acids Res       Date:  1999-02-15       Impact factor: 16.971

Review 9.  Genomic variants in exons and introns: identifying the splicing spoilers.

Authors:  Franco Pagani; Francisco E Baralle
Journal:  Nat Rev Genet       Date:  2004-05       Impact factor: 53.242

10.  Sulfatases and sulfatase modifying factors: an exclusive and promiscuous relationship.

Authors:  M Sardiello; I Annunziata; G Roma; A Ballabio
Journal:  Hum Mol Genet       Date:  2005-09-20       Impact factor: 6.150

View more
  7 in total

1.  Detailed molecular characterization of a novel IDS exonic mutation associated with multiple pseudoexon activation.

Authors:  L Grodecká; T Kováčová; M Kramárek; S Seneca; K Stouffs; C De Laet; F Majer; T Kršjaková; P Hujová; K Hrnčířová; P Souček; W Lissens; E Buratti; Tomas Freiberger
Journal:  J Mol Med (Berl)       Date:  2016-11-12       Impact factor: 4.599

2.  Molecular analysis of the iduronate-2-sulfatase gene in Thai patients with Hunter syndrome.

Authors:  S Keeratichamroen; J R Ketudat Cairns; D Wattanasirichaigoon; P Wasant; L Ngiwsara; P Suwannarat; S Pangkanon; J Kuptanon; P Tanpaiboon; T Rujirawat; S Liammongkolkul; J Svasti
Journal:  J Inherit Metab Dis       Date:  2008-05-20       Impact factor: 4.982

3.  A new mutation (1062 del 16) of iduronate-2-sulfatase gene from a Chinese patient with Hunter syndrome.

Authors:  Yi-bin Guo; Jing-xin Pan; Ya-xian Meng
Journal:  J Zhejiang Univ Sci B       Date:  2007-08       Impact factor: 3.066

4.  Analysis of Pathogenic Pseudoexons Reveals Novel Mechanisms Driving Cryptic Splicing.

Authors:  Niall P Keegan; Steve D Wilton; Sue Fletcher
Journal:  Front Genet       Date:  2022-01-24       Impact factor: 4.772

Review 5.  Lessons from non-canonical splicing.

Authors:  Christopher R Sibley; Lorea Blazquez; Jernej Ule
Journal:  Nat Rev Genet       Date:  2016-05-31       Impact factor: 53.242

Review 6.  Impact, Characterization, and Rescue of Pre-mRNA Splicing Mutations in Lysosomal Storage Disorders.

Authors:  Andrea Dardis; Emanuele Buratti
Journal:  Genes (Basel)       Date:  2018-02-06       Impact factor: 4.096

Review 7.  Biochemical and molecular analysis in mucopolysaccharidoses: what a paediatrician must know.

Authors:  Mirella Filocamo; Rosella Tomanin; Francesca Bertola; Amelia Morrone
Journal:  Ital J Pediatr       Date:  2018-11-16       Impact factor: 2.638

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.